Items where authors include "Pollard, K"

Export as [feed] Atom [feed] RSS
Number of items: 12.

Article

Spoletini, G, Gillgrass, L, Pollard, K et al. (5 more authors) (2022) Dose adjustments of Elexacaftor/Tezacaftor/Ivacaftor in response to mental health side effects in adults with cystic fibrosis. Journal of Cystic Fibrosis, 21 (6). pp. 1061-1065. ISSN 1569-1993

White, H, Shaw, N, Denman, S et al. (3 more authors) (2017) Variation in lung function as a marker of adherence to oral and inhaled medication in cystic fibrosis. European Respiratory Journal, 49 (3). ARTN 1600987. ISSN 0903-1936

Peckham, D, Williams, K, Wynne, S et al. (3 more authors) (2016) Fungal contamination of nebuliser devices used by people with cystic fibrosis. Journal of Cystic Fibrosis, 15 (1). pp. 74-77. ISSN 1569-1993

Peckham, D, Etherington, C, White, H et al. (9 more authors) (2014) The development and deployment of integrated electronic care records in a regional adult and paediatric cystic fibrosis unit. Journal of Cystic Fibrosis, 13 (6). pp. 681-686. ISSN 1569-1993

Peckham, D orcid.org/0000-0001-7723-1868, Watson, A, Pollard, K et al. (2 more authors) (2002) Predictors of desaturation during formal hypoxic challenge in adult patients with cystic fibrosis. Journal of Cystic Fibrosis, 1 (4). pp. 281-286. ISSN 1569-1993

Conference or Workshop Item

Haigh, L, Chadwick, HK, Gillgrass, L et al. (10 more authors) (2021) P206 Patient feedback following the introduction of a dedicated ‘Symkevi® Initiation Clinic’ prior to starting modulator therapy. In: 44th European Cystic Fibrosis Conference.

Milligan, CM, Pollard, K, Watson, R et al. (4 more authors) (2021) P86 Physiotherapist-led online exercise session for people with cystic fibrosis (CF) during the COVID-19 pandemic: a service evaluation. In: British Thoracic Society Winter Meeting, 08-12 Feb 2021, Online.

Spoletini, G, Watson, R, Pollard, K et al. (4 more authors) (2020) Nasal high-flow therapy (NHFT) during exercise in patients with cystic fibrosis (CF): a randomized crossover trial. In: 2020 ERS International Congress, 06-09 Sep 2020, Online.

Spoletini, G, Pollard, K, Watson, R et al. (4 more authors) (2019) Outcomes at 6 months following NIV in adults with cystic fibrosis (CF): experience of a large UK centre. In: ERS International Congress 2019, 28 Sep - 02 Oct 2019, Madrid, Spain.

Spoletini, G, Watson, R, Pollard, K et al. (4 more authors) (2019) Use of NIV in cystic fibrosis: 10-year experience of a large adult CF centre. In: ERS International Congress 2019, 28 Sep - 02 Oct 2019, Madrid, Spain.

Proceedings Paper

Gillgrass, L, Haigh, L, Pollard, K et al. (6 more authors) (2023) P366 Developing an in-house and integrated sweat testing service for the routine management of adults with cystic fibrosis. In: Journal of Cystic Fibrosis. 46th European Cystic Fibrosis Conference, 07-10 Jun 2023, Vienna, Austria. Elsevier , S176-S176.

Chadwick, HK orcid.org/0000-0002-8022-5490, White, H, Shaw, N et al. (5 more authors) (2018) Aztreonam lysine inhalation solution stabilises lung function decline in patients with cystic fibrosis and moderate to severe lung disease. In: Pediatric Pulmonology. NACFC 2018: the 32nd Annual North American Cystic Fibrosis Conference, 18-20 Oct 2018, Denver, CO, USA. Wiley , p. 331.

This list was generated on Sun Mar 24 13:41:53 2024 GMT.